-
EP2827840
European procedure
Extract from the Register of European Patents
EP About this file: EP2827840
| EP2827840 - CYCLOSPORIN A-BASED AQUEOUS OPHTHALMIC SOLUTION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.07.2020 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 26.07.2019 | ||
| Former | Grant of patent is intended Status updated on 02.04.2019 | ||
| Former | Examination is in progress Status updated on 01.12.2017 | Most recent event Tooltip | 10.07.2020 | No opposition filed within time limit | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states Laboratoires THEA 12, rue Louis Blériot, Zone Industrielle du Brézet 63100 Clermont-Ferrand / FR | [2019/18] |
| Former [2015/05] | For all designated states Laboratoires Théa 12, rue Louis Bléroit Zone Industrielle du Brezet 63100 Clermont-Ferrand / FR | Inventor(s) | 01 /
MURIAUX, Emmanuel 4 Rue des Galliens F-78580 Maule / FR | 02 /
MERCIER, Fabrice 34 Avenue Léon Blum F-63000 Clermont-ferrand / FR | [2015/05] | Representative(s) | Cabinet Laurent & Charras Le Contemporain 50 Chemin de la Bruyère 69574 Dardilly Cedex / FR | [2015/05] | Application number, filing date | 13715338.3 | 15.03.2013 | [2019/35] | WO2013FR50557 | Priority number, date | FR20120052583 | 22.03.2012 Original published format: FR 1252583 | US201261614218P | 22.03.2012 Original published format: US 201261614218 P | [2015/05] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO2013140071 | Date: | 26.09.2013 | Language: | FR | [2013/39] | Type: | A1 Application with search report | No.: | EP2827840 | Date: | 28.01.2015 | Language: | FR | The application published by WIPO in one of the EPO official languages on 26.09.2013 takes the place of the publication of the European patent application. | [2015/05] | Type: | B1 Patent specification | No.: | EP2827840 | Date: | 28.08.2019 | Language: | FR | [2019/35] | Search report(s) | International search report - published on: | EP | 26.09.2013 | Classification | IPC: | A61K38/13, A61K9/00, A61K9/08, A61K47/32, A61K47/44, A61K47/38, A61P27/02 | [2019/16] | CPC: |
A61K38/13 (EP,RU,US);
A61K9/08 (EP,RU,US);
A61K47/38 (RU,US);
A61K47/14 (RU,US);
A61K47/32 (EP,RU,US);
A61K9/0048 (EP,US);
A61P27/00 (EP);
A61P27/02 (EP);
A61P27/04 (EP);
A61K2121/00 (RU)
(-)
|
| Former IPC [2015/05] | A61K9/00, A61K9/08, A61K38/13, A61K47/14, A61K47/32, A61K47/38 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/05] | Extension states | BA | 29.08.2014 | ME | 29.08.2014 | Title | German: | CYCLOSPORIN A-BASIERTE WÄSSRIGE OPTHALMISCHE LÖSUNG | [2015/05] | English: | CYCLOSPORIN A-BASED AQUEOUS OPHTHALMIC SOLUTION | [2015/05] | French: | SOLUTION OPHTALMIQUE AQUEUSE A BASE DE CICLOSPORINE A | [2015/05] | Entry into regional phase | 29.08.2014 | National basic fee paid | 29.08.2014 | Designation fee(s) paid | 29.08.2014 | Examination fee paid | Examination procedure | 18.07.2013 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 29.08.2014 | Examination requested [2015/05] | 12.05.2015 | Amendment by applicant (claims and/or description) | 05.12.2017 | Despatch of a communication from the examining division (Time limit: M04) | 21.03.2018 | Reply to a communication from the examining division | 03.04.2019 | Communication of intention to grant the patent | 18.07.2019 | Fee for grant paid | 18.07.2019 | Fee for publishing/printing paid | 18.07.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 05.12.2017 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/33] | Fees paid | Renewal fee | 27.03.2015 | Renewal fee patent year 03 | 31.03.2016 | Renewal fee patent year 04 | 31.03.2017 | Renewal fee patent year 05 | 30.03.2018 | Renewal fee patent year 06 | 30.03.2019 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]WO9323010 (SANDOZ AG [AT], et al); | [I]EP1142566 (MEDIDOM LAB [CH]); | [I]US2002173516 (CHEN JIAQI [CN], et al); | [XI]WO2009046967 (FOVEA PHARMACEUTICALS SA [FR], et al); | [XI]WO2009058585 (BAUSCH & LOMB [US], et al); | [I]WO2009088570 (SIRION THERAPEUTICS INC [US], et al); | [ID]WO2009099467 (ALLERGAN INC [US], et al); | by applicant | WO2009099467 |